Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Lasch

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Critical Care Medicine|December 1, 1996
Pain assessment in seriously ill patients: its importance and need for technical improvementK Lasch, D B Carr
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Selenium therapy in colorectal tumors?]K Lasch, C Bräsel, H Jahn
International Journal of Health Services : Planning, Administration, Evaluation|January 1, 1997
The potential role of unemployment benefits in shaping the mental health impact of unemploymentE Rodriguez, K Lasch, J P Mead
International Journal of Technology Assessment in Health Care|December 11, 1986
A protocol approach to assessing medical technologiesK Lasch, A Maltz, F Mosteller, et al.
Psychiatry Research|July 1, 1990
Birth-cohort changes in the rates of maniaK Lasch, M Weissman, P Wickramaratne, et al.
Journal of Palliative Medicine|February 13, 2002
Why study pain? A qualitative analysis of medical and nursing faculty and students' knowledge of and attitudes to cancer pain managementK Lasch, A Greenhill, G Wilkes, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2018
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' replyU Mahadevan, S Vermeire, K Lasch, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2017
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel diseaseU Mahadevan, S Vermeire, K Lasch, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2017
Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' replyU Mahadevan, S Vermeire, K Lasch, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2016
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialB G Feagan, H Patel, J-F Colombel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Critical Care Medicine|December 1, 1996
Pain assessment in seriously ill patients: its importance and need for technical improvementK Lasch, D B Carr
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Selenium therapy in colorectal tumors?]K Lasch, C Bräsel, H Jahn
International Journal of Health Services : Planning, Administration, Evaluation|January 1, 1997
The potential role of unemployment benefits in shaping the mental health impact of unemploymentE Rodriguez, K Lasch, J P Mead
International Journal of Technology Assessment in Health Care|December 11, 1986
A protocol approach to assessing medical technologiesK Lasch, A Maltz, F Mosteller, et al.
Psychiatry Research|July 1, 1990
Birth-cohort changes in the rates of maniaK Lasch, M Weissman, P Wickramaratne, et al.
Journal of Palliative Medicine|February 13, 2002
Why study pain? A qualitative analysis of medical and nursing faculty and students' knowledge of and attitudes to cancer pain managementK Lasch, A Greenhill, G Wilkes, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2018
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' replyU Mahadevan, S Vermeire, K Lasch, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2017
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel diseaseU Mahadevan, S Vermeire, K Lasch, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2017
Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' replyU Mahadevan, S Vermeire, K Lasch, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2016
Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialB G Feagan, H Patel, J-F Colombel, et al.
Pageof 2